BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19441605)

  • 21. Quality of life assessment in patients with moderate to severe allergic rhinitis treated with montelukast and/or intranasal steroids: a randomised, double-blind, placebo-controlled study.
    Goh BS; Ismail MI; Husain S
    J Laryngol Otol; 2014 Mar; 128(3):242-8. PubMed ID: 24618303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis.
    Anolik R;
    Ann Allergy Asthma Immunol; 2008 Mar; 100(3):264-71. PubMed ID: 18426147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring.
    Philip G; Malmstrom K; Hampel FC; Weinstein SF; LaForce CF; Ratner PH; Malice MP; Reiss TF;
    Clin Exp Allergy; 2002 Jul; 32(7):1020-8. PubMed ID: 12100048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.
    Ratner PH; Howland WC; Arastu R; Philpot EE; Klein KC; Baidoo CA; Faris MA; Rickard KA
    Ann Allergy Asthma Immunol; 2003 May; 90(5):536-42. PubMed ID: 12775135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of intranasal triamcinolone acetonide with oral loratadine for the treatment of patients with seasonal allergic rhinitis.
    Schoenwetter W; Lim J
    Clin Ther; 1995; 17(3):479-92. PubMed ID: 7585852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.
    Martin BG; Andrews CP; van Bavel JH; Hampel FC; Klein KC; Prillaman BA; Faris MA; Philpot EE
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):851-7. PubMed ID: 16802774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis.
    Meltzer EO; Philip G; Weinstein SF; LaForce CF; Malice MP; Dass SB; Santanello NC; Reiss TF
    Am J Rhinol; 2005; 19(6):591-8. PubMed ID: 16402647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients.
    Patel P; Patel D
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):287-94. PubMed ID: 18814452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies.
    Chervinsky P; Philip G; Malice MP; Bardelas J; Nayak A; Marchal JL; van Adelsberg J; Bousquet J; Tozzi CA; Reiss TF
    Ann Allergy Asthma Immunol; 2004 Mar; 92(3):367-73. PubMed ID: 15049402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
    van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Montelukast in the treatment of allergic rhinitis: an evidence-based review.
    Nayak A; Langdon RB
    Drugs; 2007; 67(6):887-901. PubMed ID: 17428106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.
    Mucha SM; deTineo M; Naclerio RM; Baroody FM
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):164-72. PubMed ID: 16490874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.
    Ciebiada M; Górska-Ciebiada M; DuBuske LM; Górski P
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):664-71. PubMed ID: 17165277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma].
    Benitez HH; Arvizu VM; Gutiérrez DJ; Fogelbach GA; Castellanos Olivares A; Vázquez Nava F; Velázquez HC; González Pérez Mdel C; Mora Nieto A; Rodríguez EC
    Rev Alerg Mex; 2005; 52(2):90-5. PubMed ID: 16158782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenylephrine hydrochloride modified-release tablets for nasal congestion: a randomized, placebo-controlled trial in allergic rhinitis patients.
    Meltzer EO; Ratner PH; McGraw T
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):66-71. PubMed ID: 26560899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis.
    Hung CH; Hua YM; Hsu WT; Lai YS; Yang KD; Jong YJ; Chu YT
    Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Meta-analysis of leukotriene receptor antagonist montelukast in the treatment of allergic rhinitis].
    Lu Y; Yin M; Cheng L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Aug; 49(8):659-67. PubMed ID: 25351124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
    Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
    Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma.
    Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
    Clin Exp Allergy; 2001 Apr; 31(4):616-24. PubMed ID: 11359431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of levocetirizine compared with montelukast in subjects with ragweed-induced seasonal allergic rhinitis in the Environmental Exposure Unit.
    Day JH; Briscoe MP; Ratz JD
    Allergy Asthma Proc; 2008; 29(3):304-12. PubMed ID: 18387222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.